Candidate potency assay for ex vivo modulation of umbilical cord blood with 16,16-dimethyl prostaglandin E2: Adaptation of the ISHAGE gating strategy to evaluate increased CXCR4 on CD34+ cells
Year: 2015
Type: article
Source: Cytotherapy
Authors: Betsy Rezner, Thuy Le, David Robbins, Pratik Multani, Daniel Shoemaker, Mary Wloch
Institution: Fate Therapeutics (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2093331629